Skip to main content
VIYASH SCIENTIFIC LIMITED logo

VIYASH SCIENTIFIC LIMITED — Investor Relations & Filings

Ticker · VIYASH ISIN · INE807F01027 LEI · 335800SXM7D3VSHF2X07 BSE.NS Manufacturing
Filings indexed 1,420 across all filing types
Latest filing 2025-08-08 AGM Information
Country IN India
Listing BSE.NS VIYASH

About VIYASH SCIENTIFIC LIMITED

https://www.viyash.com

Viyash Scientific Limited is an integrated pharmaceutical platform specializing in the development and manufacturing of Active Pharmaceutical Ingredients (APIs), advanced intermediates, and finished dosage forms. The organization operates a network of manufacturing facilities supported by robust research and development capabilities, focusing on complex chemistry and niche therapeutic segments. Its core business activities encompass the entire pharmaceutical value chain, from process development and scale-up to commercial-scale production. The company provides integrated solutions to global partners, leveraging its technical expertise in chemical synthesis and commitment to international quality standards. By maintaining a focus on operational excellence and innovation, the company serves as a strategic partner in the global healthcare supply chain, delivering high-quality medicinal components and formulations.

Recent filings

Filing Released Lang Actions
Shareholders meeting
AGM Information Classification · 95% confidence The document is a detailed summary of the proceedings of the 40th Annual General Meeting (AGM) of Sequent Scientific Limited held on August 8, 2025. It includes information about the meeting's conduct, attendees, resolutions passed, and voting procedures. The document references the AGM explicitly multiple times and provides a comprehensive overview of the meeting rather than just announcing the meeting or voting results. It does not contain financial statements or detailed financial performance data, so it is not an Annual Report or Interim Report. It is not a voting results declaration alone, as it summarizes the entire meeting proceedings. Therefore, the document fits the category of AGM Information (AGM-R). The document length (9953 characters) supports that it is a full summary rather than a brief announcement.
2025-08-08 English
Summary of Proceeding of the 40th Annual General Meeting of the Company held on Friday, August 8, 2025
AGM Information Classification · 100% confidence The document is a detailed summary of the proceedings of the 40th Annual General Meeting (AGM) of Sequent Scientific Limited held on August 8, 2025. It includes information about the meeting's conduct, attendees, resolutions passed, and voting procedures. The document references the AGM explicitly multiple times and provides a comprehensive overview of the meeting rather than just announcing the meeting or voting results. It does not contain financial statements or detailed financial performance data, so it is not an Annual Report (10-K) or Interim Report (IR). It is not a voting results declaration (DVA) because it summarizes the meeting proceedings rather than just the voting outcomes. Therefore, the document fits the category of AGM Information (AGM-R), which covers presentations and materials shared during the AGM, including summaries of proceedings.
2025-08-08 English
Proposed change in Management
Board/Management Information Classification · 100% confidence The document is an official intimation to stock exchanges regarding a proposed change in the management structure of SeQuent Scientific Limited, specifically detailing the appointment of a new Managing Director and the transition of the current CEO. This falls under the category of Board/Management Information.
2025-08-08 English
Outcome of Board Meeting
Board/Management Information Classification · 100% confidence The document is an official intimation to stock exchanges regarding a proposed change in the management structure of SeQuent Scientific Limited, specifically detailing the appointment of a new Managing Director and the transition of the current CEO. This falls under the category of Board/Management Information.
2025-08-08 English
Press Release & Investor presentation for Q1 FY 26
Interim / Quarterly Report Classification · 100% confidence The document is dated August 8, 2025, and is addressed to stock exchanges with a subject line indicating it contains a Press Release and Investor Presentation for Q1 FY 2025-26. It includes detailed unaudited standalone and consolidated financial results for the quarter ended June 30, 2025, with revenue, EBITDA, and PAT figures, as well as commentary from the Managing Director. The document also announces an upcoming earnings call. The presence of detailed financial data and analysis for a quarter, along with management commentary and forward-looking statements, indicates this is a comprehensive quarterly financial report. The document is about 15,000 characters long, which is substantial and contains actual financial data, not just an announcement or certification. Therefore, it fits the definition of an Interim / Quarterly Report (IR). Q1 2026
2025-08-08 English
Analysts/Institutional Investor Meet/Con. Call Updates
Interim / Quarterly Report Classification · 100% confidence The document is dated August 8, 2025, and contains detailed financial results for the quarter ended June 30, 2025 (Q1 FY 2025-26). It includes consolidated financial highlights such as revenues, EBITDA, PAT, and growth percentages. The text explicitly mentions "Press Release & Investor Presentation for Q1 FY 2025-26" and includes a detailed investor presentation section with performance updates, business highlights, and forward-looking statements. There is also mention of an upcoming earnings call. The document is about quarterly financial results with substantive financial data and analysis, not just a brief announcement or a certification. Therefore, it fits the definition of an Interim / Quarterly Report (IR). Q1 2026
2025-08-08 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.